Reduced expression of limd1 in ulcerative oral epithelium: Associated with tobacco and areca nut

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 9, 2012, Pages 4341-4346

  Maiti, Guru Prasad ^a   Ghosh, Amlan ^a   Chatterjee, Ramdas ^b   Roy, Anup ^c   Sharp, Tyson V ^d   Roychoudhury, Susanta ^e   Panda, Chinmay Kumar ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^b Oral Cancer Foundation   (India)

^c NORTH BENGAL MEDICAL COLLEGE   (India)

^d INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

EGFR; LIMD1; Premalignant oral lesions; RB; RBSP3; SH3GL2

Indexed keywords

EID: 84874015455     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.9.4341     Document Type: Article

References (22)

1. Califano J, van der Riet P, Westra W et al (1996). Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res, 56, 2488-92.
2. Dikic I. Mechanisms controlling (2003). EGF receptor endocytosis and degradation. Biochem Soc Trans, 31, 1178-81.
3. Foxler DE, James V, Shelton SJ, et al (2011). PU.1 is a major transcriptional activator of the tumour suppressor gene LIMD1. FEBS letters, 585, 1089-96.
4. Ghosh A, Ghosh S, Maiti GP et al (2009). SH3GL2 and CDKN2A/2B loci are independently altered in early dysplastic lesions of head and neck: correlation with HPV infection and tobacco habit. J Pathol, 217, 408-19.
5. Ghosh A, Ghosh S, Maiti GP et al (2010). Frequent alterations of the candidate genes hMLH1, ITGA9 and RBSP3 in early dysplastic lesions of head and neck: clinical and prognostic significance. Cancer Sci, 101, 1511-20.
6. Ghosh S, Ghosh A, Maiti GP et al (2010). LIMD1 is more frequently altered than RB1 in head and neck squamous cell carcinoma: clinical and prognostic implications. Mol Cancer, 9, 58.
7. Leemans CR, Braakhuis BJ, Brakenhoff RH (2010). The molecular biology of head and neck cancer. Nature reviews 2010, 11, 9-22.
8. Muñoz-Corcuera M, Esparza-Gómez G, González-Moleset al (2009).Oral ulcers: clinical aspects. A tool for dermatologists. Part II. Chronic ulcers. Clinical and Experimental Dermatology, 34, 456-461.
9. Mitsudomi T, Yatabe Y (2007). Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer. Cancer Sci, 98, 1817-24.
10. Mitra S, Banerjee S, Misra C et al (2007). Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population. Journal of clinical pathology, 60, 1040-7.
11. Pandya S, Chaudhary AK, Singh M, Singh M, Mehrotra R (2009). Correlation of histopathological diagnosis with habits and clinical findings in oral submucous fibrosis. Head & Neck Oncology, 1, 10.
12. Perez-Ordonez B, Beauchemin M, Jordan RC (2006). Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol, 59, 445-53.
13. Perrone F, Suardi S, Pastore E et al (2006). Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma. Clin Cancer Res, 12, 6643-51.
14. Ren Y, Xu HW, Davey F et al (2008). Endophilin I expression is increased in the brains of Alzheimer disease patients. J Biol Chem, 283, 5685-91.
15. Sengupta S, Chakrabarti S, Roy A et al (2007). Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype. Cancer, 109, 703-12.
16. Sharp TV, Al-Attar A, Foxler DE et al (2008). The chromosome 3p21.3-encoded gene, LIMD1, is a critical tumor suppressor involved in human lung cancer development. Proc Natl Acad Sci U S A, 105, 19932-7.
17. Sinha S, Singh RK, Alam N et al (2008). Frequent alterations of hMLH1 and RBSP3/HYA22 at chromosomal 3p22.3 region in early and late-onset breast carcinoma: clinical and prognostic significance. Cancer Sci, 99, 1984-91.
18. Sinha S, Chunder N, Mukherjee N et al (2008). Frequent deletion and methylation in SH3GL2 and CDKN2A loci are associated with early- and late-onset breast carcinoma. Ann Surg Oncol, 1, 1070-80.
19. Spendlove I, Al-Attar A, Watherstone O et al (2008). Differential subcellular localisation of the tumour suppressor protein LIMD1 in breast cancer correlates with patient survival. Int J Cancer, 123, 2247-53.
20. Wu Y, Evers BM, Zhou BP (2009). Small C-terminal domain phosphatase enhances snail activity through dephosphorylation. The Journal of biological chemistry, 284, 640-8.
21. Yeo M, Lin PS, Dahmus ME, Gill GN (2003). A novel RNA polymerase II C-terminal domain phosphatase that preferentially dephosphorylates serine 5. J Biol Chem, 278, 26078-85.
22. Zhang L, Michelsen C, Cheng X et al (1997). Molecular analysis of oral lichen planus. A premalignant lesion? Am J Pathol, 151, 323-7.